A recent study published in Springer May 2025 Experimental Brain Research has demonstrated significant benefits of NovaVision's NeuroEyeCoach for patients undergoing vision rehabilitation, whether in a home or clinic setting. This development is crucial as it supports the growing trend towards digital health solutions that can be accessed remotely, offering a cost-effective and accessible option for patients worldwide.
The study, a collaboration between the Neurorehabilitation unit of the Neuromotor and Cognitive Rehabilitation Research Centre, University of Verona, Italy, and NovaVision, compared the outcomes of 95 patients using NeuroEyeCoach at home with 31 patients in a clinic setting. It found that both groups showed improvements in visual search times, made fewer errors, and reported reduced subjective disability, with no significant differences between the two settings.
NeuroEyeCoach, developed by Vycor Medical's NovaVision division, is designed to aid patients recovering from visual impairments caused by stroke or brain injury. The program trains patients to make better eye movements, improving their ability to detect objects in their visual field. This study builds on previous research, including a 296-patient peer-reviewed clinical study published in Cortex, which also highlighted the program's efficacy.
The implications of this study are far-reaching, particularly in regions where access to specialist vision rehabilitation is limited. By validating the effectiveness of home-based digital therapies, NeuroEyeCoach offers a viable solution to bridge the gap in care, ensuring more patients can benefit from vision rehabilitation regardless of their location. This aligns with the global shift towards telehealth and digital health solutions, marking a significant step forward in making essential therapies more accessible to those in need.
